RedC is on a global mission to save lives by developing an innovative process and technologies that produce safe universal Red Blood Cells for transfusions in situations requiring medical intervention such as trauma, childbirth, operations, chronic illness, cancer and more. RedC Biotech's universal red blood cells will also be used as a unique platform for advanced therapies.
RedC is developing a quality process resulting with synchronized cultures of red blood cells, produced using state of the art materials
RedC will produce red blood cells in large volume bioreactors, allowing production in masses required to fulfill the global supply
Production in large volumes leads to economy of scale, lower run rates, lower testing costs and procurement of raw materials at low prices
RedC will produce red blood cells in manufacturing plants in several regions around the world, allowing on-time supply of blood units upon demand
Need and Challenges
Red blood cell transfusions are essential in many medical interventions ranging from trauma, surgery, chronic illness and cancer treatments, to childbirth emergencies
Red blood cells (Erythrocytes) are the oxygen carrying capacity of the body
Globally, nearly 120 million blood units are donated every year, yet there is a constant shortage of millions of units
Complex Supply Chain
Practices and administration of blood from donors to the patients are complex procedures from blood collection logistics, screening, testing and storage to delivery
This industry is constantly challenged to ensure the safety of the donated blood, test type matching and vigilance of current and emerging diseases to avoid transmittance of undesired donor blood elements
Availability and Cost
Blood inventories are managed carefully in each country
but frequently are operating at low risky levels, requiring the need for special donations and blood drives. The complex supply chain and the need for extra testing, matching and continuous handling affects the pricing of blood units
In the Search for a Reliable Source
There is a global need to replace this century old practice with a method that is safe, clean, accessible and cost effective and remove the need for donors from this life saving process
There is a need for new blood...
RedC Universal Red Blood Cell Transfusions
One Blood Type Fits All
The universal red blood cells provided by RedC will be a blood type that is suitable for almost every patient and will have the same potency as the currently used red blood cell transfusion
Pathogen free, no undesirable blood components, uniform
Eliminating the need for donors, volunteers and seasonal shortages
Assures effective production, will not require additional testing in hospitals
Saves Lives Worldwide
Access and availability provided worldwide – where and when needed
Industrial Red Blood Cell Production
Innovative 3D stem cell cultivation in chemically defined serum-free media
Multi-patent protected, exclusively licensed core technology
Large scale production
Red blood cell production will move from lab scale to large scale bioreactors
Uniform, undifferentiated, self-renewable, efficiently cultured human stem cells cultivated as single-cells in suspension
At an extremely high cell concentration the cells are differentiated to become Red Blood Cells
Red Blood Cells are harvested, rinsed, concentrated, packed and distributed
Economy of scale - orders of magnitude cheaper
Selection and sourcing of advanced raw materials
From Lab to Global Production - Scaling the Count of Red Blood Cells
Red C Biotech is a pre-clinical, development stage company aiming at saving lives worldwide. RedC is developing a new, process, to create universal red blood cells from stem cells.
It is a highly scalable process for production that can meet the global demand for reliable and pathogen free red blood cell transfusions.
RedC collaborates with leading industry, academia and government organizations.